inhaled mosliciguat
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Pulmovant, Inc.
Overview
inhaled mosliciguat is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
inhaled mosliciguat clinical trials
Explore related
Medical disclaimer. This page summarizes research about inhaled mosliciguat for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.